Non-peptide agonists and positive allosteric modulators of glucagon-like peptide-1 receptors: alternative approaches for treatment of Type 2 diabetes
Ongoing technical advances in CSC-targeted therapies Advanced technologies have significantly increased our ability to analyze CSCs, providing deeper insights into their heterogeneity, plasticity, and interactions within the TME
Consult your healthcare provider if you need help selecting effective/backup forms of birth control
Insulin regimens may include NPH insulin every 12 hours, frequent doses of rapid-acting insulin, or an IV insulin drip
, L-carnitine Liquid Forte , , , ,
online Supplementary Table S2) during an inpatient or emergency room visit